Short-Term Assessment of Obstructive Sleep Apnea Syndrome Remission Rate after Sleeve Gastrectomy: a Cohort Study.


Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
11 2019
Historique:
pubmed: 28 7 2019
medline: 23 5 2020
entrez: 27 7 2019
Statut: ppublish

Résumé

Severe obesity is associated with a high prevalence of moderate-to-severe obstructive sleep apnea syndrome (OSA). Bariatric surgery has been shown to effectively reduce excess weight and comorbidities. We evaluated the remission rate of moderate-to-severe OSA (apnea-hypopnea index (AHI) ≥ 15) following sleeve gastrectomy. We performed a single-center retrospective chart review of all patients who underwent preoperative polysomnography (PSG) or polygraphy before primary sleeve gastrectomy. Patients with moderate-to-severe OSA treated by continuous positive airway pressure (CPAP) also underwent postoperative PSG. Bivariate analysis was performed to evaluate the criteria associated with remission of moderate-to-severe OSA. From 2013 to 2018, 39 of 162 patients (24.1%) scheduled for sleeve gastrectomy (SG) presented moderate-to-severe OSA requiring CPAP. Postoperative PSG was performed in 36 patients a mean of 9.9 ± 6.1 months after SG. Mean BMI decreased from 47.4 ± 8.4 to 36.3 ± 7.1 kg/m SG is associated with a rapid improvement of moderate-to-severe OSA partially as a result of a reduction of neck circumference. However, the absence of correlation with excess weight loss suggests that other weight-independent factors may also be involved.

Sections du résumé

BACKGROUND
Severe obesity is associated with a high prevalence of moderate-to-severe obstructive sleep apnea syndrome (OSA). Bariatric surgery has been shown to effectively reduce excess weight and comorbidities.
METHODS
We evaluated the remission rate of moderate-to-severe OSA (apnea-hypopnea index (AHI) ≥ 15) following sleeve gastrectomy. We performed a single-center retrospective chart review of all patients who underwent preoperative polysomnography (PSG) or polygraphy before primary sleeve gastrectomy. Patients with moderate-to-severe OSA treated by continuous positive airway pressure (CPAP) also underwent postoperative PSG. Bivariate analysis was performed to evaluate the criteria associated with remission of moderate-to-severe OSA.
RESULTS
From 2013 to 2018, 39 of 162 patients (24.1%) scheduled for sleeve gastrectomy (SG) presented moderate-to-severe OSA requiring CPAP. Postoperative PSG was performed in 36 patients a mean of 9.9 ± 6.1 months after SG. Mean BMI decreased from 47.4 ± 8.4 to 36.3 ± 7.1 kg/m
CONCLUSION
SG is associated with a rapid improvement of moderate-to-severe OSA partially as a result of a reduction of neck circumference. However, the absence of correlation with excess weight loss suggests that other weight-independent factors may also be involved.

Identifiants

pubmed: 31346929
doi: 10.1007/s11695-019-04110-0
pii: 10.1007/s11695-019-04110-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3690-3697

Références

J Clin Sleep Med. 2008 Aug 15;4(4):333-8
pubmed: 18763424
Obes Surg. 2014 Jan;24(1):22-31
pubmed: 23856989
Surg Obes Relat Dis. 2013 Jan-Feb;9(1):21-5
pubmed: 23201209
Arch Surg. 2012 Aug;147(8):694-700
pubmed: 22508671
J Clin Sleep Med. 2017 Mar 15;13(3):479-504
pubmed: 28162150
Obes Surg. 2016 Jul;26(7):1384-90
pubmed: 26559426
Obes Surg. 2004 Jun-Jul;14(6):755-62
pubmed: 15318977
Ann N Y Acad Sci. 2012 Aug;1264:110-34
pubmed: 22827862
Obes Surg. 2013 Mar;23(3):414-23
pubmed: 23299507
Ann Med Psychol (Paris). 1984 Jun;142(6):862-5
pubmed: 6524792
Surg Obes Relat Dis. 2017 Jan;13(1):95-100
pubmed: 27720196
Sleep Med. 2009 Feb;10(2):226-32
pubmed: 18387341
Rev Mal Respir. 2010 Sep;27(7):806-33
pubmed: 20863987
Obes Surg. 2016 Feb;26(2):429-42
pubmed: 26661105
Encephale. 1986 Mar-Apr;12(2):77-9
pubmed: 3743520
Psychol Rep. 1974 Jun;34(3):1184-6
pubmed: 4424377
Obes Surg. 2018 May;28(5):1402-1407
pubmed: 29204779
N Engl J Med. 2007 Aug 23;357(8):741-52
pubmed: 17715408
JAMA Surg. 2018 Jun 1;153(6):526-533
pubmed: 29450469
Proc Am Thorac Soc. 2008 Feb 15;5(2):136-43
pubmed: 18250205
Surg Obes Relat Dis. 2016 Jan;12(1):70-4
pubmed: 25862184
Rev Port Pneumol (2006). 2016 Nov - Dec;22(6):331-336
pubmed: 27339391
Surg Endosc. 2017 Jan;31(1):245-248
pubmed: 27177951
Sleep Med Rev. 2017 Dec;36:57-70
pubmed: 27919588
Surg Obes Relat Dis. 2016 May;12(4):757-762
pubmed: 26806727
Surg Obes Relat Dis. 2016 Dec;12(10):1866-1872
pubmed: 27234342
Front Endocrinol (Lausanne). 2018 Aug 06;9:440
pubmed: 30127766

Auteurs

Marine Timmerman (M)

Department of Endocrinology, Metabolic Diseases and Nutrition, University Hospital Amiens-Picardie, 80054, Amiens Cedex, France.

Damien Basille (D)

Department of Respiratory Diseases and Intensive Care Unit, University Hospital Amiens-Picardie, 80054, Amiens Cedex, France. basille.damien@chu-amiens.fr.
AGIR Unit, University Picardie Jules Verne, 80054, Amiens Cedex, France. basille.damien@chu-amiens.fr.

Aurélie Basille-Fantinato (A)

Sleep and Vigilance Disorder Unit, University Hospital Amiens-Picardie, 80054, Amiens Cedex, France.

Mickaël E Baud (ME)

Department of Respiratory Diseases and Intensive Care Unit, University Hospital Amiens-Picardie, 80054, Amiens Cedex, France.

Lionel Rebibo (L)

Department of Digestive Surgery, University Hospital Amiens-Picardie, 80054, Amiens Cedex, France.
Department of Digestive, Esogastric and Bariatric Surgery, Bichat Claude Bernard University Hospital, 46 rue Henri Huchard, F-75018, Paris, France.

Claire Andrejak (C)

Department of Respiratory Diseases and Intensive Care Unit, University Hospital Amiens-Picardie, 80054, Amiens Cedex, France.
AGIR Unit, University Picardie Jules Verne, 80054, Amiens Cedex, France.
Sleep and Vigilance Disorder Unit, University Hospital Amiens-Picardie, 80054, Amiens Cedex, France.

Vincent Jounieaux (V)

Department of Respiratory Diseases and Intensive Care Unit, University Hospital Amiens-Picardie, 80054, Amiens Cedex, France.
AGIR Unit, University Picardie Jules Verne, 80054, Amiens Cedex, France.
Sleep and Vigilance Disorder Unit, University Hospital Amiens-Picardie, 80054, Amiens Cedex, France.

Jean-Daniel Lalau (JD)

Department of Endocrinology, Metabolic Diseases and Nutrition, University Hospital Amiens-Picardie, 80054, Amiens Cedex, France.
PériTox Unit, UMR-I 01, University Picardie Jules Verne, 80054, Amiens Cedex, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH